Arbor Biotechnologies to Present at the Evercore ISI GenomeRx Emerging Therapeutics Conference and the Jefferies Virtual Healthcare Conference

CAMBRIDGE, MA – June 1, 2021 -

Arbor Biotechnologies^®, an early-stage life sciences company discovering and developing the next generation of genetic medicines, announced today that it will present at two upcoming virtual investor conferences:

• Evercore ISI GenomeRx Emerging Therapeutics Conference on Thursday, June 3, 2021, as one of a select group of companies invited to present
• Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 at 9:00am

Devyn Smith, CEO, and other members of Arbor’s management team will participate in one-on-one meetings with life science investors at both events.